Globus Medical Inc. held its 2025 Annual Meeting of Stockholders on June 4, 2025. Stockholders approved the amendment to the 2021 Equity Incentive Plan and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Additionally, a non-binding advisory vote to approve the compensation of the company's named executive officers was approved. Stockholders also recommended holding an advisory vote on executive compensation every year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.